AIM
GILD icon

Advantage Investment Management’s Gilead Sciences GILD Stock Holding History

Advantage Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$203K Sell
3,197
-1,126
-26% -$73.6K 0.16% 145
2019
Q2 		$292K Sell
4,323
-265
-6% -$17.4K 0.22% 85
2019
Q1 		$298K Sell
4,588
-272
-6% -$18.1K 0.23% 79
2018
Q4 		$304K Buy
4,860
+903
+23% +$63.1K 0.23% 77
2018
Q3 		$306K Buy
3,957
+1,198
+43% +$90.5K 0.2% 92
2018
Q2 		$195K Sell
2,759
-68
-2% -$4.8K 0.14% 130
2018
Q1 		$213K Buy
2,827
+200
+8% +$15.9K 0.08% 153
2017
Q4 		$188K Sell
2,627
-382
-13% -$29K 0.06% 188
2017
Q3 		$244K Buy
3,009
+531
+21% +$40.6K 0.08% 155
2017
Q2 		$175K Buy
2,478
+135
+6% +$8.98K 0.06% 176
2017
Q1 		$159K Sell
2,343
-430
-16% -$30.2K 0.06% 169
2016
Q4 		$199K Sell
2,773
-54
-2% -$4.01K 0.07% 145
2016
Q3 		$224K Buy
2,827
+663
+31% +$53.9K 0.08% 129
2016
Q2 		$181K Sell
2,164
-530
-20% -$47K 0.09% 142
2016
Q1 		$247K Buy
2,694
+515
+24% +$46.4K 0.11% 112
2015
Q4 		$221K Sell
2,179
-360
-14% -$37.5K 0.11% 126
2015
Q3 		$249K Buy
2,539
+375
+17% +$41.6K 0.14% 107
2015
Q2 		$253K Hold
2,164
– – 0.12% 121
2015
Q1 		$212K Sell
2,164
-98
-4% -$9.95K 0.12% 139
2014
Q4 		$213K Buy
+2,262
New +$234K 0.16% 118

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advantage Investment Management's GILD Position: Q3 2019 in Review

Advantage Investment Management reduced its Gilead Sciences (GILD) stake by 26% in Q3 2019, selling an estimated $73.6K and leaving 3,197 shares worth $203K. The position accounts for 0.16% of the portfolio, ranked #145.

Advantage Investment Management first reported a position in GILD in Q4 2014 and has held it in 20 quarters since. The position peaked at $306K in Q3 2018. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Advantage Investment Management held 3,197 shares of Gilead Sciences worth $203K as of Q3 2019.
  • Advantage Investment Management sold 1,126 Gilead Sciences shares in Q3 2019, an estimated $73.6K.
  • Gilead Sciences made up 0.16% of Advantage Investment Management's portfolio in Q3 2019, its #145 holding.
  • Advantage Investment Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's Gilead Sciences position peaked at $306K in Q3 2018.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.